Say what you will about Goldman Sachs (GS) - and folks have had a lot to say about the firm lately, much of it less than laudatory - but its stock continues to resonate with shareholders.
Critics have thrown several fresh shovelfuls of dirt on the wounded duck they want it to be. But the assault has had as much effect as snowballs have when they’re thrown against a tank. Maybe it’s true, what Rolling Stone said about the firm in its profile last month: Goldman really, really is a giant vampire squid.
It’s a term of art that’s gathered increasing currency in the Fourth Estate, especially among the suburban players in the digital divide, where balance can be a more-elusive quality than it is for their counterparts in the brick-and-mortar publishing ranks. It’s a remarkable descriptor to get behind, given that so few of us in the ranks of financial bloggers could distinguish between a cephalopod and a botanist, and whose only congress with squid comes when it’s quickly grilled with a nice olive oil and squirt of fresh lemon. But the notion of Goldman attaching itself to the face of humanity, as Rolling Stone suggested last month, represented the kind of visual that qualifies as too compelling for scribblers to pass up.
Recently:
- ‘Vampire’ Stars’ Flashing Charges Dismissed
- Vampire endorsement turns Brontë into bestseller
- The Omnipotent Giant Vampire Squid Thrives On
- The New Twilight Barbie: She Digs Vampires
- When did vampires turn from monsters to sex symbols?
- Vampire Bats Biting More People Due to Amazon Development
- Vampire-Con 2009: The world’s first vampire convention
- Brother-In-Law Thinks Ronnie Wood Is Vampire
- Why Britney Spears needs a vampire boyfriend
- Headmaster: No Vampires At Our School
